| Mr Patrick Walker, PT, CSCS | |
|
2714 Philadelphia Pike # A, Claymont, DE 19703-2568 | |
| (302) 408-7310 | |
| (302) 416-4817 |
| Full Name | Mr Patrick Walker |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 2714 Philadelphia Pike # A, Claymont, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356779268 | NPI | - | NPPES |
| 1356779268 | Medicaid | DE | |
| 3015873 | Other | DE | HIGHMARK |
| 3915382000 | Other | PA | IBC |
| 50132206 | Other | PA | CAPITAL BC |
| 3015873 | Other | PA | HIGHMARK |
| AC44-0062 | Other | DE | CAREFIRST |
| 3930195000 | Other | DE | AMERIHEALTH (IBC) |
| 103007320 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT016048 (Pennsylvania) | Secondary |
| 225100000X | Physical Therapist | J1-0001811 (Delaware) | Primary |
| Provider Name | Walkermovementgroup Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1386317170 PECOS PAC ID: 2961867262 Enrollment ID: O20230419003076 |
News Archive
Three previous meta-analyses reported that, compared to the Structured Clinical Interview for the DSM (SCID), alternative reference standards, primarily the Composite International Diagnostic Interview (CIDI) and the Mini International Neuropsychiatric Interview (MINI), tended to misclassify major depression status, when controlling for depression symptom severity. However, there was an important lack of precision in the results.
Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India.
IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes - like adding table salt to a formulation or changing a pill's color."
Pain researchers from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Medical Center have discovered that resiniferatoxin, a drug that has shown early promise as an option for chronic, severe pain sufferers, may decrease the body's ability to fight off bacterial infections, particularly sepsis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Patrick Walker, PT, CSCS 1311 Mamaroneck Ave Ste 140, White Plains, NY 10605-5224 Ph: (914) 294-4050 | Mr Patrick Walker, PT, CSCS 2714 Philadelphia Pike # A, Claymont, DE 19703-2568 Ph: (302) 408-7310 |
News Archive
Three previous meta-analyses reported that, compared to the Structured Clinical Interview for the DSM (SCID), alternative reference standards, primarily the Composite International Diagnostic Interview (CIDI) and the Mini International Neuropsychiatric Interview (MINI), tended to misclassify major depression status, when controlling for depression symptom severity. However, there was an important lack of precision in the results.
Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India.
IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes - like adding table salt to a formulation or changing a pill's color."
Pain researchers from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Medical Center have discovered that resiniferatoxin, a drug that has shown early promise as an option for chronic, severe pain sufferers, may decrease the body's ability to fight off bacterial infections, particularly sepsis.
› Verified 2 days ago
Emanuela Mannino, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2714 Philadelphia Pike, Claymont, DE 19703 Phone: 302-408-7310 | |
Ryan Tagliamonte, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2714 Philadelphia Pike, Claymont, DE 19703 Phone: 302-408-7310 Fax: 302-916-4817 | |
Patricia Fannya Manchak, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2714 Philadelphia Pike, Claymont, DE 19703 Phone: 302-408-7310 Fax: 302-416-4817 | |
Karen Conner, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 | |
Samantha Orr, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2714 Philadelphia Pike, Claymont, DE 19703 Phone: 302-408-7310 | |
Judith Voge, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Pennsylvania Ave, Claymont, DE 19703 Phone: 302-792-3994 |